Recognizing IBP (inflammatory back pain) vs MBP (mechanical back pain)
An Adaptive Learning Experience Sponsored by Novartis Pharmaceutical Corporation; Not for CME/CE Credit
Non-CME Unbranded Medical Education in collaboration with Amplifire digital Engineering learning tool
Axial spondyloarthritis (axSpA) is a chronic and debilitating inflammatory disease primarily affecting the spine and sacroiliac joints. In the United States alone, it is estimated to take 14 years to receive appropriate diagnosis as it's hallmark symptom, inflammatory back pain, can go unnoticed or be misdiagnosed. Due to the challenges in recognizing axSpA, patients are often referred to various healthcare providers in the journey to diagnosis. There is a significant need to increase the proper diagnosis of axSpA among healthcare professionals, especially those that are seeing patients experiencing back pain. Early identification and timely referral to rheumatologists can help mitigate the progressive structural damage and significant patient burden in axSpA patients.
This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.
Amplifire uses brain science and an adaptive algorithm that adjusts the experience to tailor content to meet your learning needs. Here’s how it’s different: you will be asked questions before you start learning. Research shows that answering questions prepares your brain to learn, and it helps make new concepts stick. In addition, the questions are used to customize your experience.